Genmab AS (GMAB)
20.65
+0.18
(+0.88%)
USD |
NASDAQ |
Nov 22, 16:00
20.92
+0.27
(+1.31%)
After-Hours: 20:00
Genmab Profit Margin (Quarterly): 22.85% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 22.85% |
| June 30, 2024 | 26.06% |
| March 31, 2024 | 31.98% |
| December 31, 2023 | 14.77% |
| September 30, 2023 | 44.65% |
| June 30, 2023 | 32.02% |
| March 31, 2023 | 7.41% |
| December 31, 2022 | 10.01% |
| September 30, 2022 | 63.18% |
| June 30, 2022 | 59.80% |
| March 31, 2022 | 21.94% |
| December 31, 2021 | 26.04% |
| September 30, 2021 | 38.53% |
| June 30, 2021 | 15.52% |
| March 31, 2021 | 69.32% |
| December 31, 2020 | 28.42% |
| September 30, 2020 | 30.74% |
| June 30, 2020 | 61.97% |
| March 31, 2020 | 30.16% |
| December 31, 2019 | 49.71% |
| September 30, 2019 | 51.63% |
| June 30, 2019 | 10.98% |
| March 31, 2019 | 12.18% |
| December 31, 2018 | 67.47% |
| September 30, 2018 | 29.93% |
| Date | Value |
|---|---|
| June 30, 2018 | 51.12% |
| March 31, 2018 | 29.16% |
| December 31, 2017 | 77.28% |
| September 30, 2017 | -1.76% |
| June 30, 2017 | 39.73% |
| March 31, 2017 | 6.42% |
| December 31, 2016 | 90.72% |
| September 30, 2016 | 51.82% |
| June 30, 2016 | 47.55% |
| March 31, 2016 | -6.77% |
| December 31, 2015 | 67.77% |
| September 30, 2015 | 50.50% |
| June 30, 2015 | 9.48% |
| March 31, 2015 | |
| December 31, 2014 | 31.98% |
| September 30, 2014 | 58.90% |
| June 30, 2014 | -22.55% |
| March 31, 2014 | 39.87% |
| December 31, 2013 | 27.71% |
| September 30, 2013 | 3.57% |
| June 30, 2013 | -18.35% |
| March 31, 2013 | 45.37% |
| December 31, 2012 | -220.6% |
| September 30, 2012 | -48.13% |
| June 30, 2012 | -1.86% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
7.41%
Minimum
Mar 2023
69.32%
Maximum
Mar 2021
34.25%
Average
30.45%
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk AS | 38.28% |
| Ascendis Pharma AS | -171.5% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -64.14% |
| IO Biotech Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.86% |
| Return on Assets | 12.66% |
| Return on Invested Capital | 14.86% |
| Gross Profit Margin (Quarterly) | 95.07% |
| Operating Margin (Quarterly) | 38.25% |
| Return on Net Operating Assets | 35.82% |